Andreas Mayerhofer-Von Ameln
Sindelfingen, BW 71065, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Multicenter Renal Pharmacist Group-Pharmaceutical Care for Patients with Renal Impairment at Four Non-University Hospitals in Germany.
Journal: Journal of clinical medicine
Published: May 29, 2025
Clinically Relevant Interactions with Anti-Infectives on Intensive Care Units-A Multicenter Delphi Study.
Journal: Antibiotics (Basel, Switzerland)
Published: September 30, 2021
Modulating endothelial adhesion and migration impacts stem cell therapies efficacy.
Journal: EBioMedicine
Published: June 30, 2020
MDMA modulates spontaneous firing of subthalamic nucleus neurons in vitro.
Journal: Experimental brain research
Published: January 05, 2014
Chronic co-administration of the cannabinoid receptor agonist WIN55,212-2 during puberty or adulthood reverses 3,4 methylenedioxymetamphetamine (MDMA)-induced deficits in recognition memory but not in effort-based decision making.
Journal: Pharmacology, biochemistry, and behavior
Published: November 02, 2012
Is behavioral sensitization to 3,4-methylenedioxymethamphetamine (MDMA) mediated in part by cholinergic receptors?
Journal: Behavioural brain research
Published: September 11, 2012
Short- and long-term unilateral 6-hydroxydopamine lesions in rats show different changes in characteristics of spontaneous firing of substantia nigra pars reticulata neurons.
Journal: Experimental brain research
Published: April 27, 2012
6-Hydroxydopamine leads to T2 hyperintensity, decreased claudin-3 immunoreactivity and altered aquaporin 4 expression in the striatum.
Journal: Behavioural brain research
Published: February 10, 2012
Imaging DA release in a rat model of L-DOPA-induced dyskinesias: a longitudinal in vivo PET investigation of the antidyskinetic effect of MDMA.
Journal: NeuroImage
Published: February 06, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026